Novo Nordisk CEO signals new appetite for risk in obesity deals – Reuters
- Novo Nordisk CEO signals new appetite for risk in obesity deals Reuters
- Novo Nordisk walked away from a $10 billion biotech deal — and investors aren’t sure if that’s smart or scary CNBC
- Top Midday Stories: Over 1,400 Flights Canceled Monday and Counting; Pfizer to Acquire Metsera for up to $86.25 per Share MarketScreener
- Novo Nordisk’s Killer Non-Acquisition Merger Contract Proposal Is a Case of “Heads I Win, Tails You Lose” promarket.org
- Transcript: Pfizer and Novo Nordisk’s $10bn battle over weight-loss drugs Financial Times